Firethorn Wealth Partners’s Antares Pharma, Inc. ATRS Stock Holding History

Firethorn Wealth Partners’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-84,069	Closed	-$345K	–	148
2022 Q1	$345K	Buy	84,069 +28,249	+51%	+$102K	0.26%	81
2021 Q4	$199K	Buy	+55,820	New	+$195K	0.15%	129
2021 Q2	$210K	Buy	48,179 +3,650	+8%	+$14.9K	0.18%	117
2021 Q1	$183K	Buy	44,529 +17,300	+64%	+$75K	0.17%	122
2020 Q4	$109K	Buy	+27,229	New	+$88.1K	0.12%	100

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Firethorn Wealth Partners's ATRS Position: Q2 2022 in Review

Firethorn Wealth Partners sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 84,069 shares — an estimated $345K sold.

Firethorn Wealth Partners first reported a position in ATRS in Q4 2020 and held it in 5 quarters. The position peaked at $345K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Firethorn Wealth Partners reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Firethorn Wealth Partners sold 84,069 Antares Pharma, Inc. shares in Q2 2022, an estimated $345K.
Firethorn Wealth Partners first reported a position in Antares Pharma, Inc. in Q4 2020 and held it in 5 quarters.
Firethorn Wealth Partners's Antares Pharma, Inc. position peaked at $345K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Firethorn Wealth Partners's 13F filing for Q2 2022, filed 3 Aug 2022.